Call for Abstract
3rd International Conference on Metabolomics, Genomics and Proteomics, will be organized around the theme “Novel Trends in Metabolomics, Genomics and Proteomics research”
Metabolomics Congress 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Metabolomics Congress 2021
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.
Metabolomics is a novel approaches those potentials to enable the detection of states of disease, to categories the patients based on biochemical and metabolomics profiles and to monitor disease progression. Metabolomics analysis may also be able to orient the choice of therapy, identify responders and predict toxicity, paving the way to a customized therapy. Metabolomics approach has revealed new opportunities in diagnostics of devastating disorders like neuropsychiatric disorders, Metabolic Disorders, Cardiovascular Diseases, Metabolomics studies in Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Osteoarthritis, Gouty Arthritis, Nephrology and Many more diseases.
Using Metabolomics, a better understanding of the correlation between biochemical composition and genes of plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function (genotype). Four joint U.S. also, Japanese research groups have been recompensed subsidizing totalling about $12 million (about Yen 960 million) to grow new indeed well-disposed strategies to expand the creation of renewable biofuel and lessen pesticide use.
Clinical metabolomics involves the application of clinical laboratory protocols, standards, and oversight of a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.
Food and Nutritional metabolomics are rapidly maturing to use small molecule chemical profiling to support the integration of diet and nutrition in complex bio systems research. These developments are critical to facilitate the transition of nutritional sciences from population-based to individual-based criteria for nutritional research, assessment, and management. Improved analytics tools and databases for targeted and non-targeted metabolic profiling, along with bioinformatics, pathway mapping, and computational modelling, are now used for nutrition research on diet, metabolism, microbiome and health associations. These new developments enable metabolome-wide association studies (MWAS) and provide a foundation for nutritional metabolomics, along with genomics, epigenomics, and health phenotyping, to support integrated models required for a personalized diet and nutrition forecasting.
Genomics is an interdisciplinary field of science concentrating on the structure, work, advancement, mapping, and altering of genomes. A genome is a life form's entire arrangement of DNA and including the greater part of its qualities. Rather than hereditary qualities, which alludes to the investigation of individual qualities and their parts in legacy, genomics goes for the aggregate portrayal and evaluation of qualities, which coordinate the generation of proteins with the help of compounds and ambassador particles. Genomics deals the scientific study of complex diseases such as heart disease, diabetes, asthma, and cancer because these diseases are typically caused more by a combination of environmental and genetic factors than by individual genes.
Clinical genomics is the use of genome sequencing to advise quiet analysis and care and it is a rapidly growing field. Genome sequencing is depended upon to have the best in portraying and diagnosing extraordinary and obtained contaminations, stratifying individuals' tumors to manage treatment (precision sedate), giving information around an individual's threat of making illness or their comprehensible response to treatment.
The development of biotechnology, genetic engineering, and cloning has opened many possibilities of protein expression and isolation of heterologous proteins for research purposes. The ability to produce and purify an abundance of a desired recombinant protein can permit a wide range of possibilities including, its use in industrial processes, or its use to diagnose or treat disease. For large scale applications such as an antibody, enzyme, or vaccine production, the amount of protein required is significantly high, in such cases, the system in which the user of expression of the protein is must be easy to culture and maintain, grow rapidly, and produce large amounts of protein. Protein analysis is the bioinformatics study of protein structure, it’s interaction and function which are present in complex biological samples.
Proteomics is the scientific discipline which studies and searches for proteins that are associated with the disease by means of their altered levels of sequence. Each level of protein structure is essential to the finished molecule’s function. The focus of proteomics is a biological group called proteome (set of protein sequence).
Applications of proteomics in the discovery of new diagnostic, prognostic and therapeutic targets cover a wide range of example applications for the most important diseases, such as heart and cardiovascular disorders, cancer, pharmatoxicology, infectious diseases and diseases of the nervous system.
Constant genome sequence acts differently in different cell types, responds to the environment, and changes throughout our lives. Chemical modifications to the genome sequence and to the proteins that package the genome, known collectively as the epigenome, are a major contributor to the changes in genome function between cell types and over time.